Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Precigen Inc’s stock clocked out at $2.03, up 0.50% from its previous closing price of $2.02. In other words, the price has increased by $0.50 from its previous closing price. On the day, 1.62 million shares were traded.
Ratios:
To gain a deeper understanding of PGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.63. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 150.13 while its Price-to-Book (P/B) ratio in mrq is 10.74.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 71.93%, while the 200-Day Moving Average is calculated to be 69.17%.
Shares Statistics:
A total of 292.87M shares are outstanding, with a floating share count of 162.71M. Insiders hold about 44.44% of the company’s shares, while institutions hold 26.16% stake in the company.
